FITC Plus Anti-Human CD71 (OKT9)
CD71 Monoclonal Antibody for FC
Host / Isotype
Mouse / IgG1, kappa
Reactivity
Human and More (2)
Applications
IF, FC
Conjugate
FITC Plus Fluorescent Dye
CloneNo.
OKT9
Cat no : FITC-65235
Synonyms
Validation Data Gallery
Tested Applications
Positive FC detected in | Human PBMC |
Recommended dilution
Application | Dilution |
---|---|
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 μl per 10^6 cells in a 100 µl suspension or 5 μl per 100 µl of whole blood. | |
Sample-dependent, Check data in validation data gallery. |
Published Applications
IF | See 1 publications below |
Product Information
FITC-65235 targets CD71 in IF, FC applications and shows reactivity with Human samples.
Tested Reactivity | Human |
Cited Reactivity | human, mouse |
Host / Isotype | Mouse / IgG1, kappa |
Class | Monoclonal |
Type | Antibody |
Immunogen | Human T-cell acute lymphoblastic leukemia cells 相同性解析による交差性が予測される生物種 |
Full Name | transferrin receptor (p90, CD71) |
Calculated molecular weight | 85 kDa |
GenBank accession number | BC001188 |
Gene symbol | CD71 |
Gene ID (NCBI) | 7037 |
Conjugate | FITC Plus Fluorescent Dye |
Excitation/Emission maxima wavelengths | 495 nm / 524 nm |
Form | Liquid |
Purification Method | Affinity purification |
Storage Buffer | PBS with 0.09% sodium azide and 0.5% BSA. |
Storage Conditions | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Background Information
CD71, also known as transferrin receptor protein 1 (TfR1), is a transmembrane glycoprotein composed of two disulfide-linked monomers, each of 90 kDa molecular weight. Each monomer binds one holo-transferrin molecule creating an iron-Tf-TfR complex that enters the cell by endocytosis. CD71 is present on actively proliferating cells and is essential for iron transport into proliferating cells.
Protocols
Product Specific Protocols | |
---|---|
FC protocol for FITC Plus CD71 antibody FITC-65235 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Cell Chem Biol Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor |